AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
AEON Biopharma, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.23−0.00 (-0.43%)
Close on Oct 19, 2026
- Market cap
- $11.67M
- P/E (TTM)
- –
- Dividend yield
- –
AEON Biopharma statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | AEON Biopharma | Industry median |
|---|---|---|
| Market Cap | $11.52M | $197.05M |
| Enterprise Value | $8.09M | $106.56M |
Income (trailing twelve months)
| Measure | AEON Biopharma | Industry median |
|---|---|---|
| Operating Income | -$19.86M | -$21.44M |
| Pretax Income | -$54.62M | -$14.45M |
| Net Income | -$54.62M | -$22.46M |
| EBITDA | -$19.78M | -$16.91M |
Returns
| Measure | AEON Biopharma | Industry median |
|---|---|---|
| Return on Assets (ROA) | -621.7% | -41.0% |
Balance sheet
| Measure | AEON Biopharma | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $3.43M | $62.42M |
| Net Cash (Debt) | $3.43M | $15.68M |
| Net Cash Per Share | $0.07 | $0.65 |
| Equity (Book Value) | -$15.36M | $48.79M |
| Book Value Per Share | -$0.31 | $1.36 |
| Tangible Book Value | -$15.36M | $23.06M |
| Working Capital | -$3.35M | $75.77M |
Financial position
| Measure | AEON Biopharma | Industry median |
|---|---|---|
| Current Ratio | 0.54 | 3.30 |
| Quick Ratio | 0.47 | 2.39 |
Cash flow (trailing twelve months)
| Measure | AEON Biopharma | Industry median |
|---|---|---|
| Operating Cash Flow | -$13.64M | -$12.35M |
Efficiency
| Measure | AEON Biopharma | Industry median |
|---|---|---|
| Profits Per Employee | -$6.83M | -$732.08K |
| Employee Count | 8 | 73 |
Dividends and yields
| Measure | AEON Biopharma | Industry median |
|---|---|---|
| Earnings Yield | -474.0% | -21.2% |
Shares
| Measure | AEON Biopharma | Industry median |
|---|---|---|
| Shares Outstanding | 49,882,800 | 59,128,900 |
| Shares Change (YoY) | 613.8% | 11.1% |
| Shares Change (QoQ) | 3.97% | 0.54% |
| Float | 5,060,060 | 48,744,500 |
| Shares Held by Insiders | 89.9% | 11.8% |
| Shares Held by Institutions | 25.7% | 59.4% |
Scores
| Measure | AEON Biopharma | Industry median |
|---|---|---|
| Altman Z-Score | -126.04 | 0.10 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from AEON Biopharma's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.